Evidence map›Paper›PMID 32431922›Full record

ArticleActa crystallographica. Section E, Crystallographic communications2020

Crystal structure, Hirshfeld surface analysis and inter-action energy, DFT and anti-bacterial activity studies of ethyl 2-[(2

Ghizlane Sebbar, Ellouz Mohamed, Tuncer Hökelek, Joel T Mague, Nada Kheira Sebbar, El Mokhtar Essassi, Bouchra Belkadi

Abstract read
In one paragraph

Article in Acta crystallographica. Section E, Crystallographic communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Crystal structure and Hirshfeld surface analyses, inter-action energy calculations and energy frameworks of (Acta crystallographica. Section E, Crystallographic communications · 2026
    Article
  2. Crystal structures, Hirshfeld surface analysis and inter-action energies of (Acta crystallographica. Section E, Crystallographic communications · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ghizlane SebbarLaboratory of Microbiology and Molecular Biology, Faculty of Sciences, University Mohammed V, Rabat, Morocco.
Ellouz MohamedLaboratoire de Chimie Organique Heterocyclique URAC 21, Pole de Competence Pharmacochimie, Faculté des Sciences, Université Mohammed V, Rabat, Morocco.
Tuncer HökelekDepartment of Physics, Hacettepe University, 06800 Beytepe, Ankara, Turkey.
Joel T MagueDepartment of Chemistry, Tulane University, New Orleans, LA 70118, USA.ORCID https://orcid.org/0000-0003-3488-1945
Nada Kheira SebbarLaboratoire de Chimie Organique Heterocyclique URAC 21, Pole de Competence Pharmacochimie, Faculté des Sciences, Université Mohammed V, Rabat, Morocco.
El Mokhtar EssassiLaboratoire de Chimie Organique Heterocyclique URAC 21, Pole de Competence Pharmacochimie, Faculté des Sciences, Université Mohammed V, Rabat, Morocco.
Bouchra BelkadiLaboratory of Microbiology and Molecular Biology, Faculty of Sciences, University Mohammed V, Rabat, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The title compound, C

Indexed as

anti­bacterial activitycrystal structuredi­hydro­benzo­thia­zineHirshfeld surfacehydrogen bond

Identifiers

PMID32431922
PMCPMC7199248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.